Peptide CAS Number: Evidence and Mechanism Explained

A peptide CAS number is an identifier for a substance registered in the Chemical Abstracts Service database. It can help distinguish and retrieve a defined chemical substance, but it does not explain what a peptide does. The number contains no biological information about receptor binding, metabolic effects, potency, safety or clinical evidence.

That distinction matters because peptide discussions often collapse three separate questions into one: What material is this? How might it affect biology? What has research shown in humans? A CAS Registry Number can contribute to the first answer. It cannot answer the other two.

What a CAS Registry Number actually identifies

CAS assigns a unique numeric identifier, called a CAS Registry Number or CAS RN, when a substance enters CAS REGISTRY. The numbers are assigned sequentially and have no inherent chemical meaning. In other words, the digits do not encode an amino-acid sequence, molecular target or therapeutic category. The official CAS REGISTRY overview describes CAS as the authority for these identifiers and warns that third-party sources can associate the wrong number with a substance.

The final digit is a check digit. It can be used to determine whether a CAS number is structurally valid, which may reveal some transcription errors. Passing that check does not prove that the number belongs to the peptide named beside it. A syntactically valid identifier can still be copied into the wrong catalog entry.

Nor does the existence or absence of a verified CAS RN determine whether a peptide is biologically active or supported by research. Substances enter CAS REGISTRY through indexed literature or a registration request. A missing identifier is therefore an information gap, not evidence that the underlying peptide is invalid.

Why the sequence alone may not settle peptide identity

Peptides are chains of amino acids, but a complete material description can require much more than the letter sequence. CAS registration information for biological substances may include sequence data and the positions of disulfide bridges. Registration criteria can also distinguish stereochemical forms, salts and specified salt ratios.

A useful peptide identity record may need to state:

The exact amino-acid sequence and residue count
The stereochemistry of the residues, including any noncanonical amino acids
The chemical state of the N-terminus and C-terminus, such as amidation
Disulfide-bond connectivity where applicable
The salt or counterion and its stoichiometric ratio
Any defined hydrate or solvate form

This is why one sequence should not automatically be assigned every CAS number associated with a related material. A free peptide and its acetate salt, for example, can represent distinct registered substances. The PubChem record for sermorelin acetate describes an acetate salt of a synthetic, amidated 29-amino-acid peptide and displays a CAS number for that salt-form record. That identifier should not be generalized to every material sharing the peptide sequence.

The same distinction is useful when reading about MOTS-c acetate. The peptide sequence, its defined material form and the evidence for its proposed metabolic activity are related subjects, but they are not interchangeable facts.

What a peptide CAS number does not prove

Question	Relevant information	What a CAS RN contributes
What substance is intended?	Sequence, modifications, stereochemistry and material form	A database identifier for a registered substance
What is in this specific lot?	Identity testing, purity analysis and impurity data	No lot-specific evidence
How does it affect biology?	Receptor binding, signaling and functional studies	No mechanism information
What happens in people?	Human trials, safety data and approved labeling	No clinical evidence
Is it approved for medical use?	Current records from the relevant regulator	No proof of approval

PubChem can be valuable for inspecting chemical records, structures and linked information, but its documentation explains that CAS identifiers may appear as depositor-provided synonyms or third-party annotations. Their display in PubChem should not automatically be interpreted as independent validation by PubChem.

CAS identity is not metabolic mechanism

Mechanism begins with biology: which receptor or molecular target a peptide engages, what signaling pathway follows, which tissues are affected and whether those effects have been demonstrated rather than merely proposed. For metabolic peptides, that can involve appetite signaling, insulin secretion, glucagon activity, gastric emptying, nutrient handling or energy expenditure.

None of those properties can be inferred from a CAS number. Even knowing that a compound is a peptide provides limited pharmacological information. For example, semaglutide is a modified peptide, but understanding its effects requires examining GLP-1 receptor pharmacology, structural modifications, exposure and clinical trials—not its chemical identifier.

FDA uses a specific regulatory definition under which a peptide is an alpha-amino-acid polymer containing 40 or fewer amino acids, while a protein contains more than 40. FDA emphasizes that definition for regulatory purposes; it is not a universal scientific boundary governing every use of the word “peptide.”

The agency’s clinical-pharmacology guidance treats pharmacokinetics, safety, immunogenicity, QTc risk, hepatic impairment and drug interactions as development considerations for peptide drug products. These characteristics require experimental and clinical evaluation. They are not encoded in a registry number. FDA’s peptide drug guidance provides the regulatory context.

CAS numbers are not approval numbers

Chemical registration and regulatory approval are separate systems. A CAS RN does not show that a product has been reviewed, authorized or approved for use in humans. The same caution applies to other identity systems. FDA’s Global Substance Registration System assigns Unique Ingredient Identifiers, or UNIIs, from scientific identity characteristics, but FDA explicitly states that the existence of a UNII does not imply regulatory review or approval.

Approval status instead has to be checked through current regulatory records and, where relevant, official prescribing information. Investigational status, trial results and sponsor announcements also need to be evaluated independently of chemical identifiers.

How to evaluate a peptide CAS reference

A reliable reference should do more than place a peptide name beside a string of digits. It should define the material precisely, trace the identifier to an authoritative record and avoid implying that identity establishes quality or biological performance.

Confirm the peptide’s exact sequence and terminal modifications.
Determine whether the entry refers to a free form, salt, hydrate or another defined form.
Check stereochemistry, unusual residues and disulfide connectivity where relevant.
Verify the CAS RN against CAS or a traceable authoritative record rather than copying an unsupported vendor listing.
Keep analytical quality data separate from substance identity.
Evaluate mechanism from biochemical and pharmacological evidence.
Evaluate human effects, safety and regulatory status from trials, labeling and regulatory records.

This layered approach follows the broader principle in our evidence and methodology framework: match each question to the evidence capable of answering it. A CAS number can be useful and specific, but its role is narrow. It helps identify a registered substance; it does not authenticate a batch, reveal a metabolic mechanism or establish that a peptide works in people.